ClinicalTrials.govpublic full text
Non-immunogenic Recombinant Staphylokinase vs Placebo in Patients With Intermediate High-risk Pulmonary Embolism
pulmonary embolism, intermediate high-risk pulmonary embolism, fibrinolysis, recombinant non-immunogenic staphylokinase, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 992244
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.